Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2015

Study Completion Date

June 15, 2019

Conditions
Pancreatic Cancer
Interventions
DRUG

erlotinib hydrochloride

oral administration

DRUG

gemcitabine hydrochloride

Intravenous administration

PROCEDURE

therapeutic conventional surgery

Trial Locations (24)

10016

NYU Cancer Institute at New York University Medical Center, New York

21215

Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore

21229

St. Agnes Hospital Cancer Center, Baltimore

23606

Surgical Oncology Associates, Newport News

26506

Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown

29303

Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg

33805

Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland

39216

University of Mississippi Cancer Clinic, Jackson

45409

David L. Rike Cancer Center at Miami Valley Hospital, Dayton

45415

Samaritan North Cancer Care Center, Dayton

45420

CCOP - Dayton, Dayton

45429

Charles F. Kettering Memorial Hospital, Kettering

46237

St. Francis Hospital Cancer Care Services, Indianapolis

68114

Methodist Estabrook Cancer Center, Omaha

74136

Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa

90027

Kaiser Permanente Medical Center - Los Angeles, Los Angeles

92868

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange

92093-0658

Rebecca and John Moores UCSD Cancer Center, La Jolla

06606

St. Vincent's Medical Center, Bridgeport

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

45373-1300

UVMC Cancer Care Center at Upper Valley Medical Center, Troy

97213-2967

Providence Cancer Center at Providence Portland Medical Center, Portland

53792-6164

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

OSI Pharmaceuticals

INDUSTRY

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00733746 - Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | Biotech Hunter | Biotech Hunter